Nail toxicity and Malacoplakia gastrointestinal - from FDA reports

There is no Malacoplakia Gastrointestinal reported by people with Nail Toxicity yet. We study people who have Malacoplakia Gastrointestinal and Nail Toxicity from FDA. Find out below who they are, other conditions they have and drugs they take.

On Jul, 21, 2018

No report is found.

What's next

You could also:

Related studies

Nail Toxicity

Nail toxicity (nail damaged due to toxin) (latest reports from 71 Nail toxicity patients)

Malacoplakia Gastrointestinal

Malacoplakia gastrointestinal (formation of soft patches of the mucous membrane of a gastrointestinal tract) has been reported by people with immunodeficiency disorders, kidney transplant, transplant rejection, high blood pressure, infection (latest reports from 21 Malacoplakia gastrointestinal patients).

Drugs that are associated with Malacoplakia gastrointestinal
Malacoplakia gastrointestinal (10 drugs)
Other conditions that could cause Malacoplakia gastrointestinal
Malacoplakia gastrointestinal (17 conditions)
Browse all symptoms of Nail toxicity
a b c d e f g h i j k l m n o p q r s t u v w x y z

You are not alone. Join our personalized support groups:

Recent updates

General studies
Active Support Groups
Latest posts

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.